Contact
searchSearch
HMP Global
Alexis Ogdie
Conference Coverage
Alexis Ogdie, MD, on New and Emerging Therapies for Psoriatic Arthritis
11/05/2025
Alexis Ogdie, MD
Dr Ogdie provides updates on new and emerging therapies for psoriatic arthritis, which she presented at the ACR Convergence in Chicago.
Dr Ogdie provides updates on new and emerging therapies for psoriatic arthritis, which she presented at the ACR Convergence in Chicago.
Dr Ogdie provides updates on new...
11/05/2025
Rheumatology & Arthritis
Laura Coates
Conference Coverage
Laura Coates, MBChB, on Progression to Psoriatic Arthritis from Psoriasis
11/03/2025
Laura Coates, MBChB
Dr Coates discusses her presentation at ACR Convergence on a study that found the risk of developing psoriatic arthritis was lowest among patients with psoriasis who were treated with IL-17 inhibitors compared to those treated with IL-23,...
Dr Coates discusses her presentation at ACR Convergence on a study that found the risk of developing psoriatic arthritis was lowest among patients with psoriasis who were treated with IL-17 inhibitors compared to those treated with IL-23,...
Dr Coates discusses her...
11/03/2025
Rheumatology & Arthritis
Conference Coverage
ERIN Registry Offers First Real-World Look at Rheumatic irAEs from Checkpoint Inhibitors
10/31/2025
Riya Gandhi, MA
Early data from the ERIN registry reveal diverse rheumatic immune-related adverse events (rh-irAEs), with RA-like polyarthritis and age-specific SpA phenotypes dominating presentations—highlighting the need for tailored management approaches.
Early data from the ERIN registry reveal diverse rheumatic immune-related adverse events (rh-irAEs), with RA-like polyarthritis and age-specific SpA phenotypes dominating presentations—highlighting the need for tailored management approaches.
Early data from the ERIN...
10/31/2025
Rheumatology & Arthritis
Conference Coverage
Smoking Modifies Link Between PTSD and Rheumatoid Arthritis Risk
10/31/2025
Riya Gandhi, MA
A large national study of U.S. veterans presented at ACR Convergence reveals that PTSD increases the risk of RA, especially in never-smokers, suggesting distinct immune mechanisms may drive disease in different exposure subgroups.
A large national study of U.S. veterans presented at ACR Convergence reveals that PTSD increases the risk of RA, especially in never-smokers, suggesting distinct immune mechanisms may drive disease in different exposure subgroups.
A large national study of U.S....
10/31/2025
Rheumatology & Arthritis
Conference Coverage
Anxiety, Depression, and Fibromyalgia Screening in RA Patients Reveals Symptom Burden Exceeding Seropositivity Rates
10/31/2025
Riya Gandhi, MA
Over 70% of rheumatoid arthritis patients who screen positive for anxiety, depression, or fibromyalgia report memory, sleep, or fatigue problems, highlighting the value of symptom checklists in noninflammatory disease assessment.
Over 70% of rheumatoid arthritis patients who screen positive for anxiety, depression, or fibromyalgia report memory, sleep, or fatigue problems, highlighting the value of symptom checklists in noninflammatory disease assessment.
Over 70% of rheumatoid arthritis...
10/31/2025
Rheumatology & Arthritis
Conference Coverage
Specialty Pharmacy Partnership Boosts Shingles Vaccine Uptake in Younger Rheumatoid Arthritis Patients
10/31/2025
Riya Gandhi, MA
A targeted workflow intervention involving pharmacists and coordinated care increased recombinant zoster vaccine uptake from 10% to over 15% among RA patients under 50—surpassing institutional goals and highlighting scalable strategies to...
A targeted workflow intervention involving pharmacists and coordinated care increased recombinant zoster vaccine uptake from 10% to over 15% among RA patients under 50—surpassing institutional goals and highlighting scalable strategies to...
A targeted workflow intervention...
10/31/2025
Rheumatology & Arthritis
Conference Coverage
CME Participation Linked to More Use of JAK Inhibitors in RA
10/29/2025
Jessica Garlewicz
Clinicians who participated in continuing medical education were more likely to switch to a Janus kinase inhibitor to treat their patients with rheumatoid arthritis after lack of response to anti-TNFs.
Clinicians who participated in continuing medical education were more likely to switch to a Janus kinase inhibitor to treat their patients with rheumatoid arthritis after lack of response to anti-TNFs.
Clinicians who participated in...
10/29/2025
Rheumatology & Arthritis
Conference Coverage
Genetic and Environmental Factors Together Improve Prediction of Rheumatoid Arthritis Risk
10/29/2025
Riya Gandhi, MA
A nationwide case-control study using NIH’s All of Us data reveals that integrating genetic risk with air pollution exposure—especially lead and PM2.5—substantially improves prediction of incident rheumatoid arthritis.
A nationwide case-control study using NIH’s All of Us data reveals that integrating genetic risk with air pollution exposure—especially lead and PM2.5—substantially improves prediction of incident rheumatoid arthritis.
A nationwide case-control study...
10/29/2025
Rheumatology & Arthritis
Conference Coverage
Rheumatoid Arthritis Burden Varies Widely Across U.S. States
10/29/2025
Riya Gandhi, MA
A new analysis of Global Burden of Disease (GBD) 2021 data highlights major state-by-state differences in rheumatoid arthritis burden, with older adults, women, and high-smoking states bearing the greatest health impact.
A new analysis of Global Burden of Disease (GBD) 2021 data highlights major state-by-state differences in rheumatoid arthritis burden, with older adults, women, and high-smoking states bearing the greatest health impact.
A new analysis of Global Burden...
10/29/2025
Rheumatology & Arthritis
Conference Coverage
Personalized Rehab Boosts Strength, Mobility, and Fitness in Axial Spondyloarthritis
10/28/2025
Riya Gandhi, MA
An 8-week individualized training program led to significant improvements in trunk function and aerobic capacity in patients with axSpA, offering rheumatologists new data to support exercise-based interventions.
An 8-week individualized training program led to significant improvements in trunk function and aerobic capacity in patients with axSpA, offering rheumatologists new data to support exercise-based interventions.
An 8-week individualized...
10/28/2025
Rheumatology & Arthritis
Conference Coverage
IL-17A Inhibitor QX002N Improves Symptoms and Inflammation in r-axSpA by Week 16
10/28/2025
Riya Gandhi, MA
A phase III randomized trial showed QX002N significantly improved clinical outcomes and MRI-assessed inflammation in patients with radiographic axSpA, with a favorable safety profile.
A phase III randomized trial showed QX002N significantly improved clinical outcomes and MRI-assessed inflammation in patients with radiographic axSpA, with a favorable safety profile.
A phase III randomized trial...
10/28/2025
Rheumatology & Arthritis
Sofia Ramiro
Conference Coverage
Sofia Ramiro, MD, on Differences in Structural Spinal Lesions in Early axSpAand nonaxial SpA
10/28/2025
Sofia Ramiro, MD
Dr Ramiro reviews her presentation at ACR Convergence on the SPACE cohort study of the difference in structural lesions of the spine as assessed on radiographs and on MRI between patients with early axial SPA and patients with nonaxial SpA...
Dr Ramiro reviews her presentation at ACR Convergence on the SPACE cohort study of the difference in structural lesions of the spine as assessed on radiographs and on MRI between patients with early axial SPA and patients with nonaxial SpA...
Dr Ramiro reviews her...
10/28/2025
Rheumatology & Arthritis
Paras Karmacharya
Conference Coverage
Paras Karmacharya, MD, on Multimorbidity Clusters in axSpA, PsA, and PsO
10/28/2025
Paras Karmacharya, MD
Dr Karmacharya reviews his presentation from ACR Convergence a population-based study from the UK THIN database across psoriatic arthritis, psoriasis, and axial spondyloarthritis to find distinct and remarkably stable patterns of...
Dr Karmacharya reviews his presentation from ACR Convergence a population-based study from the UK THIN database across psoriatic arthritis, psoriasis, and axial spondyloarthritis to find distinct and remarkably stable patterns of...
Dr Karmacharya reviews his...
10/28/2025
Rheumatology & Arthritis
Conference Coverage
RA-Associated Lung Disease Significantly Increases Risk of Hospitalization and ICU Admission
10/27/2025
Jessica Garlewicz
Rheumatoid arthritis-associated bronchiectasis was associated with hospitalization risks comparable to rheumatoid arthritis-associated interstitial lung disease, an area the study identified as previously underreported.
Rheumatoid arthritis-associated bronchiectasis was associated with hospitalization risks comparable to rheumatoid arthritis-associated interstitial lung disease, an area the study identified as previously underreported.
Rheumatoid arthritis-associated...
10/27/2025
Rheumatology & Arthritis
Conference Coverage
Combination of TNFi and JAKi Shows Promise in Multidrug Resistant RA
10/27/2025
Jessica Garlewicz
A small study showed that combining advanced therapies showed promise in treating refractory rheumatoid arthritis.
A small study showed that combining advanced therapies showed promise in treating refractory rheumatoid arthritis.
A small study showed that...
10/27/2025
Rheumatology & Arthritis
Conference Coverage
Study Compares CDAI and EULAR Criteria for RA Response
10/27/2025
Jessica Garlewicz
While the clinical response measures showed strong agreement in most areas, some discordance was found.
While the clinical response measures showed strong agreement in most areas, some discordance was found.
While the clinical response...
10/27/2025
Rheumatology & Arthritis
Conference Coverage
GWAS Identifies Novel Genetic Variants Associated With RA-ILD
10/27/2025
Jessica Garlewicz
Investigators reported at ACR Convergence 2025 that a genome risk score including 5 novel single nucleotide polymorphisms provides significant improvement in discriminating interstitial lung disease among patients with rheumatoid arthritis.
Investigators reported at ACR Convergence 2025 that a genome risk score including 5 novel single nucleotide polymorphisms provides significant improvement in discriminating interstitial lung disease among patients with rheumatoid arthritis.
Investigators reported at ACR...
10/27/2025
Rheumatology & Arthritis
Conference Coverage
Real-World Study Confirms Effectiveness of Upadacitinib in Moderate-to-Severe RA
10/26/2025
Jessica Garlewicz
Response rates were similar for upadacitinib monotherapy (62.7%) and upadacitinib combined with csDMARDs (60.1%), suggesting flexibility in treatment approaches, the investigators reported at ACR Convergence.  
Response rates were similar for upadacitinib monotherapy (62.7%) and upadacitinib combined with csDMARDs (60.1%), suggesting flexibility in treatment approaches, the investigators reported at ACR Convergence.  
Response rates were similar for...
10/26/2025
Rheumatology & Arthritis
Conference Coverage
State-Level Analysis Reveals Geographic, Sex, and Smoking-Related Disparities in RA Burden
10/26/2025
Jessica Garlewicz
People over 55 and women consistently had a higher burden of disease due to rheumatoid arthritis than men, investigators reported at ACR Convergence.
People over 55 and women consistently had a higher burden of disease due to rheumatoid arthritis than men, investigators reported at ACR Convergence.
People over 55 and women...
10/26/2025
Rheumatology & Arthritis
Conference Coverage
Osteoporosis and Opioid Use Linked to Higher Acute Care Utilization in RA Patients
10/26/2025
Jessica Garlewicz
A study presented at ACR Convergence revealed that patients with osteoporosis and rheumatoid arthritis with an opioid prescription had a nearly 6-fold higher risk of 30-day emergency department use.
A study presented at ACR Convergence revealed that patients with osteoporosis and rheumatoid arthritis with an opioid prescription had a nearly 6-fold higher risk of 30-day emergency department use.
A study presented at ACR...
10/26/2025
Rheumatology & Arthritis
Bryant England
Video
Bryant England, MD, on Interstitial Lung Disease in Rheumatoid Arthritis
12/06/2024
Bryant England, MD
Dr England recaps his presentation on interstitial lung disease among patients with rheumatoid arthritis, including the importance of early detection and how to diagnose this condition,
Dr England recaps his presentation on interstitial lung disease among patients with rheumatoid arthritis, including the importance of early detection and how to diagnose this condition,
Dr England recaps his...
12/06/2024
Rheumatology & Arthritis
Conference coverage
Association Between Obesity and Autoimmune Diseases
11/21/2024
Jessica Garlewicz
A large-scale study highlights the association between obesity and increased risk for autoimmune disease.
A large-scale study highlights the association between obesity and increased risk for autoimmune disease.
A large-scale study highlights...
11/21/2024
Rheumatology & Arthritis
Conference coverage
Machine Learning Model May Predict Difficult-to-Treat RA
11/20/2024
Rebecca Mashaw
Earlier identification of patients at risk of developing difficult-to-treat rheumatoid arthritis would allow treatment to begin sooner and optimize outcomes, researchers say.
Earlier identification of patients at risk of developing difficult-to-treat rheumatoid arthritis would allow treatment to begin sooner and optimize outcomes, researchers say.
Earlier identification of...
11/20/2024
Rheumatology & Arthritis
Josh Baker
Conference coverage
Metabolic Syndrome and Response to RA Therapies
11/20/2024
Rebecca Mashaw
Metabolic syndrome is associated with lower response rates among patients with rheumatoid arthritis on biologic therapy, according to research presented at ACR Convergence 2024.
Metabolic syndrome is associated with lower response rates among patients with rheumatoid arthritis on biologic therapy, according to research presented at ACR Convergence 2024.
Metabolic syndrome is associated...
11/20/2024
Rheumatology & Arthritis
Conference coverage
Effects of Antiobesity Medications on Rheumatoid Arthritis Patients
11/19/2024
Jessica Garlewicz
A retrospective study presented at ACR Convergence suggests that antiobesity therapy may yield multiple clinical benefits, including significant weight loss, improvements in inflammatory markers, reductions in pain levels, and enhanced lipid...
A retrospective study presented at ACR Convergence suggests that antiobesity therapy may yield multiple clinical benefits, including significant weight loss, improvements in inflammatory markers, reductions in pain levels, and enhanced lipid...
A retrospective study presented...
11/19/2024
Rheumatology & Arthritis
Conference coverage
Longitudinal Cohort Study Looks for Predictors of Difficult-to-Treat RA
11/19/2024
Jessica Garlewicz
In a cohort of patients with established rheumatoid arthritis being treated with first-line biologic or targeted synthetic DMARDs, 17% developed difficult-to-treat rheumatoid arthritis over 5 years.
In a cohort of patients with established rheumatoid arthritis being treated with first-line biologic or targeted synthetic DMARDs, 17% developed difficult-to-treat rheumatoid arthritis over 5 years.
In a cohort of patients with...
11/19/2024
Rheumatology & Arthritis
Conference coverage
Study Explores Treatment Adherence in Patients With RA
11/18/2024
Jessica Garlewicz
Enhancing shared decision-making practices and considering patient preferences for administration may be pivotal in improving treatment outcomes for patients with RA.
Enhancing shared decision-making practices and considering patient preferences for administration may be pivotal in improving treatment outcomes for patients with RA.
Enhancing shared decision-making...
11/18/2024
Rheumatology & Arthritis
Jeff Sparks
News
Shifting Patterns in RA Treatment: A 20-Year Analysis of DMARD Initiation
11/18/2024
Jessica Garlewicz
The use of conventional synthetic disease-modifying antirheumatic drugs declined significantly from 2001 to 2021, as biologics and targeted synthetics rose in popularity among patients and physicians.
The use of conventional synthetic disease-modifying antirheumatic drugs declined significantly from 2001 to 2021, as biologics and targeted synthetics rose in popularity among patients and physicians.
The use of conventional...
11/18/2024
Rheumatology & Arthritis
Conference Coverage
Global Prevalence of Interstitial Lung Disease Among Patients With Rheumatoid Arthritis
11/18/2024
Riya Gandhi, MA
Subgroup analyses revealed that Africa had the highest prevalence of RA-ILD, while Europe had the lowest; socioeconomic status was inversely correlated with RA-ILD prevalence.
Subgroup analyses revealed that Africa had the highest prevalence of RA-ILD, while Europe had the lowest; socioeconomic status was inversely correlated with RA-ILD prevalence.
Subgroup analyses revealed that...
11/18/2024
Rheumatology & Arthritis
News
Preterm Delivery Risk Higher Among Women With Rheumatoid Arthritis
11/16/2024
Jessica Garlewicz
Women with rheumatoid arthritis have a significantly higher rate of preterm births in compared to a control group according to research from the GR2 Cohort and French National Perinatal Data group.
Women with rheumatoid arthritis have a significantly higher rate of preterm births in compared to a control group according to research from the GR2 Cohort and French National Perinatal Data group.
Women with rheumatoid arthritis...
11/16/2024
Rheumatology & Arthritis
News
Residual Fatigue Found Among Patients With RA in Clinical Remission
11/16/2024
Jessica Garlewicz
Although residual fatigue is prevalent among patients with rheumatoid arthritis in remission, inflammatory activity appears to have a stronger association with severe fatigue.
Although residual fatigue is prevalent among patients with rheumatoid arthritis in remission, inflammatory activity appears to have a stronger association with severe fatigue.
Although residual fatigue is...
11/16/2024
Rheumatology & Arthritis
News
Comparing Onset of Action of Therapies in Rheumatoid Arthritis
11/16/2024
Jessica Garlewicz
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to...
11/16/2024
Rheumatology & Arthritis
Conference Coverage
Barriers to Achieving Disease Control in Psoriatic Arthritis
11/16/2024
Riya Gandhi, MA
Among patients with psoriatic arthritis who achieved minimal disease activity, 40% still reported pain above the acceptable threshold after 6 months of treatment, researchers reported at ACR Convergence.
Among patients with psoriatic arthritis who achieved minimal disease activity, 40% still reported pain above the acceptable threshold after 6 months of treatment, researchers reported at ACR Convergence.
Among patients with psoriatic...
11/16/2024
Rheumatology & Arthritis
News
Upadacitinib Proves Effective in TNFi-Experienced PsA Patients
11/16/2024
Riya Gandhi, MA
Patients showed improvements across all clinical and patient-reported measures after 6 months of treatment with the Janus kinase inhibitor.
Patients showed improvements across all clinical and patient-reported measures after 6 months of treatment with the Janus kinase inhibitor.
Patients showed improvements...
11/16/2024
Rheumatology & Arthritis
Conference Coverage
Neighborhood-Level Transportation Insecurity Reduces Colorectal Cancer Screening
11/14/2024
Jessica Garlewicz
The findings of research presented at the American College of Gastroenterology scientific meeting suggest that transportation insecurity is a critical social determinant of health in individual and public health outcomes.
The findings of research presented at the American College of Gastroenterology scientific meeting suggest that transportation insecurity is a critical social determinant of health in individual and public health outcomes.
The findings of research...
11/14/2024
Gastroenterology
Conference Coverage
Treat-to-Target Tapering of TNFi Studied for Noninferiority in PsA, axSpA
01/03/2024
Priyam Vora
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic...
01/03/2024
Rheumatology & Arthritis
Conference Coverage
Rebecca Haberman, MD, on Racial and Ethnic Determinants of Psoriatic Phenotypes and Disease Activity
01/02/2024
Dr Haberman characterized a cohort of patients with psoriatic arthritis to evaluate how race, ethnicity, and sex may inform features of clinical presentation, comorbidities, disease course and outcomes.
Dr Haberman characterized a cohort of patients with psoriatic arthritis to evaluate how race, ethnicity, and sex may inform features of clinical presentation, comorbidities, disease course and outcomes.
Dr Haberman characterized a...
01/02/2024
Rheumatology & Arthritis
Conference Coverage
Positive or Negative? Multimorbidity and Disease Activity in RA
12/27/2023
Rebecca Mashaw
Investigators examined the association between multimorbidity in rheumatoid arthritis and its association with flares and remission in comparison to seropositivity.
Investigators examined the association between multimorbidity in rheumatoid arthritis and its association with flares and remission in comparison to seropositivity.
Investigators examined the...
12/27/2023
Rheumatology & Arthritis
Conference Coverage
Black Box Warning No Deterrent to JAKi Adherence in RA
12/27/2023
Rebecca Mashaw
A retrospective cohort study found that patients with rheumatoid arthritis treated with Janus kinase inhibitors were no less adherent to their medication regimen after the addition of a black box warning by the US Food and Drug Administration
A retrospective cohort study found that patients with rheumatoid arthritis treated with Janus kinase inhibitors were no less adherent to their medication regimen after the addition of a black box warning by the US Food and Drug Administration
A retrospective cohort study...
12/27/2023
Rheumatology & Arthritis
Conference Coverage
Victoria Konzett, MD, on RA Flares Based on SDAI and CDAI
12/27/2023
Priyam Vora
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on...
12/27/2023
Rheumatology & Arthritis
Conference Coverage
Dr Peter Taylor on Effectiveness of Upadacitinib in RA Pain Management
12/26/2023
Priyam Vora
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Gregory McDermott, MD: Predictors of RA-ILD and Subtypes
12/26/2023
Priyam Vora
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Breakthrough COVID-19 Infection Among RA Patients After Third Dose
12/26/2023
Priyam Vora
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC...
12/26/2023
Rheumatology & Arthritis
Kaleb Michaud
Conference Coverage
Kaleb Michaud, PhD, on 45 Years as a Rheumatoid Arthritis Patient
12/20/2023
Dr Michaud related his personal experience as a patient diagnosed with juvenile rheumatoid arthritis at the age of 3, providing perspective as both a patient and a rheumatology research scientists at ACR Convergence.
Dr Michaud related his personal experience as a patient diagnosed with juvenile rheumatoid arthritis at the age of 3, providing perspective as both a patient and a rheumatology research scientists at ACR Convergence.
Dr Michaud related his personal...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
This or That? Rieke Alten, MD, Reviews Treatment Preferences for RA Patients
12/20/2023
Priyam Vora
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Rheumatoid Arthritis and Long COVID—A Double Whammy
12/20/2023
Priyam Vora
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Is There a Window of Opportunity in Psoriatic Arthritis?
12/13/2023
Rebecca Mashaw
Early referral to rheumatologists of patients who present with symptoms of psoriatic arthritis (PsA) is associated with better clinical outcomes.
Early referral to rheumatologists of patients who present with symptoms of psoriatic arthritis (PsA) is associated with better clinical outcomes.
Early referral to...
12/13/2023
Rheumatology & Arthritis
Conference Coverage
Vibeke Strand, MD, on Results of the Phase 3 SELECT-EARLY Trial
12/12/2023
Priyam Vora
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial...
12/12/2023
Rheumatology & Arthritis
Len Calabrese
Conference Coverage
Leonard Calabrese, DO, on the Clinical Challenges of Viral Infections in Rheumatic Diseases
12/06/2023
Dr Calabrese, from Cleveland Clinic, reviews his address from the review course at ACR Convergence 2023 about caring for patients with rheumatic diseases who contract viral infections and emphasizes the need for interdisciplinary management.
Dr Calabrese, from Cleveland Clinic, reviews his address from the review course at ACR Convergence 2023 about caring for patients with rheumatic diseases who contract viral infections and emphasizes the need for interdisciplinary management.
Dr Calabrese, from Cleveland...
12/06/2023
Rheumatology & Arthritis
Lihi Eder
Conference Coverage
Lihi Eder, MD, on How Patient Sex Affects Response to Advanced Therapies for PsA
12/05/2023
Dr Eder reviews research she and colleagues conducted into how women and men respond differently to advanced therapies for psoriatic arthritis.
Dr Eder reviews research she and colleagues conducted into how women and men respond differently to advanced therapies for psoriatic arthritis.
Dr Eder reviews research she and...
12/05/2023
Rheumatology & Arthritis
Conference Coverage
JAK Inhibitors for Psoriatic Arthritis? Results of the JAK-pot Study
12/05/2023
Priyam Vora
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been...
12/05/2023
Rheumatology & Arthritis
Conference Coverage
The Hidden Disease Burden of IBD Among SpA Patients
11/27/2023
Priyam Vora
Findings of the EISER study presented at ACR Convergence 2023 confirm the prevalence of undiagnosed inflammatory bowel disease among patients with spondyloarthritis.
Findings of the EISER study presented at ACR Convergence 2023 confirm the prevalence of undiagnosed inflammatory bowel disease among patients with spondyloarthritis.
Findings of the EISER study...
11/27/2023
Advances in Inflammatory Bowel Disease Network
Conference Coverage
PsA and PsO Affecting Work Productivity?
11/20/2023
Priyam Vora
Dr Nancy Shadick explains the disease burden of psoriatic arthritis and psoriasis that interferes with a patient’s worklife.
Dr Nancy Shadick explains the disease burden of psoriatic arthritis and psoriasis that interferes with a patient’s worklife.
Dr Nancy Shadick explains the...
11/20/2023
Rheumatology & Arthritis
Lihi Eder
Conference Coverage
Lihi Eder, MD, on the Association of High-Sensitivity CRP and the RIsk of Psoriatic Arthritis
11/15/2023
Dr Eder recaps her presentation from ACR Convergence 2023 on research relating high-sensitivity C reactive protein and the risk of developing psoriatic arthritis among patients with psoriasis.
Dr Eder recaps her presentation from ACR Convergence 2023 on research relating high-sensitivity C reactive protein and the risk of developing psoriatic arthritis among patients with psoriasis.
Dr Eder recaps her presentation...
11/15/2023
Rheumatology & Arthritis
Conference Coverage
Paras Karmacharya, MD, on Identifying Distinct Phenotypes in PsA
11/15/2023
Dr Paras Karmacharya discusses the findings of the PsA Research Consortium (PARC) cohort study that underscores the need for personalized treatment approaches in psoriatic arthritis, accounting for unique disease features.
Dr Paras Karmacharya discusses the findings of the PsA Research Consortium (PARC) cohort study that underscores the need for personalized treatment approaches in psoriatic arthritis, accounting for unique disease features.
Dr Paras Karmacharya discusses...
11/15/2023
Autoimmune
Ted Mikuls
Conference Coverage
Ted Mikuls, MD, on the VARA Registry of US Veterans With RA
11/14/2023
Dr Mikuls discusses the Veterans Administration Rheumatoid Arthritis (VARA) Registry, established at the University of Nebraska Medical Center, which contains more than 3500 patient records from 17 different sites around the country.
Dr Mikuls discusses the Veterans Administration Rheumatoid Arthritis (VARA) Registry, established at the University of Nebraska Medical Center, which contains more than 3500 patient records from 17 different sites around the country.
Dr Mikuls discusses the Veterans...
11/14/2023
Rheumatology & Arthritis
Conference Coverage
Impact of Social Determinants of Health on Chronic Conditions
11/13/2023
Priyam Vora
Research presented at ACR Convergence assessed the impact of social determinants of health on patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.
Research presented at ACR Convergence assessed the impact of social determinants of health on patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.
Research presented at ACR...
11/13/2023
Rheumatology & Arthritis
Conference Coverage
Discrepancies Between Patients' and Physicians' Global Assessments in PsA
11/13/2023
Priyam Vora
Dr Proton Rahman identified factors driving disagreement between patients and physicians analyzing the data from more than 1000 participants.
Dr Proton Rahman identified factors driving disagreement between patients and physicians analyzing the data from more than 1000 participants.
Dr Proton Rahman identified...
11/13/2023
Rheumatology & Arthritis
Conference Coverage
Treatment Persistence Differs Between Men and Women with PsA
11/13/2023
Rebecca Mashaw
A study conducted in France revealed significant differences in how strongly the sexes adhered to therapies for psoriatic arthritis.
A study conducted in France revealed significant differences in how strongly the sexes adhered to therapies for psoriatic arthritis.
A study conducted in France...
11/13/2023
Rheumatology & Arthritis
Conference Coverage
Clinical-Genetic Risk Score Developed for ILD Among Patients With RA
11/12/2023
Rebecca Mashaw
A new combined clinical-genetic risk score has demonstrated superiority to clinical risk factors alone for diagnosing interstitial lung disease (ILD) among patients with rheumatoid arthritis (RA).
A new combined clinical-genetic risk score has demonstrated superiority to clinical risk factors alone for diagnosing interstitial lung disease (ILD) among patients with rheumatoid arthritis (RA).
A new combined clinical-genetic...
11/12/2023
Rheumatology & Arthritis
Conference Coverage
Joshua Baker, MD, on Response to RA Treatment Based on BMI and Adiposity
11/12/2023
Dr Baker reviews research he and colleagues conducted into responses to different therapeutic strategies for rheumatoid arthritis according to patients' body mass index and adiposity.
Dr Baker reviews research he and colleagues conducted into responses to different therapeutic strategies for rheumatoid arthritis according to patients' body mass index and adiposity.
Dr Baker reviews research he and...
11/12/2023
Rheumatology & Arthritis
Conference Coverage
The Role of Biologics in CV Risk Regulation in Rheumatoid Arthritis
11/12/2023
Rebecca Mashaw
Dr George Karpouzas explained how biologic therapies may protect against major cardiovascular events among patients with rheumatoid arthritis.
Dr George Karpouzas explained how biologic therapies may protect against major cardiovascular events among patients with rheumatoid arthritis.
Dr George Karpouzas explained...
11/12/2023
Rheumatology & Arthritis
Videos
Laura Coates, MBBS, on the Safety of Risankizumab for Psoriatic Disease
11/12/2023
Dr Laura Coates reviews research she and colleagues conducted on the safety of risankizumab for the treatment of psoriatic arthritis and psoriasis.
Dr Laura Coates reviews research she and colleagues conducted on the safety of risankizumab for the treatment of psoriatic arthritis and psoriasis.
Dr Laura Coates reviews research...
11/12/2023
Rheumatology & Arthritis
Conference Coverage
Refractory Rheumatoid Arthritis: 2 Decades of Data Show Need for More Research
11/12/2023
Rebecca Mashaw
Dr Kristin Wipfler reviews data from the FORWARD biobank on the need for more research into the refractory phenotype of rheumatoid arthritis.
Dr Kristin Wipfler reviews data from the FORWARD biobank on the need for more research into the refractory phenotype of rheumatoid arthritis.
Dr Kristin Wipfler reviews data...
11/12/2023
Rheumatology & Arthritis
Conference Coverage
Patient-Reported Outcomes in RA: Shilpa Venkatachalam, PhD
11/12/2023
Priyam Vora
Can digital health tools offer more insight outside of clinical setting in the treatment of rheumatoid arthritis? Dr Shilpa Venkatachalam spoke on the topic at ACR Convergence.
Can digital health tools offer more insight outside of clinical setting in the treatment of rheumatoid arthritis? Dr Shilpa Venkatachalam spoke on the topic at ACR Convergence.
Can digital health tools offer...
11/12/2023
Rheumatology & Arthritis
Lihi Eder, MD
Conference Coverage
Lihi Eder, MD, on Metabolic Disorders and Diet Among Patients With Psoriatic Disease
08/14/2023
Priyam Vora
Dr Eder, from the University of Toronto, presented a poster at ACR Convergence on research that sheds light into how metabolic disorders and abnormal dietary patterns affect psoriatic arthritis disease activity.
Dr Eder, from the University of Toronto, presented a poster at ACR Convergence on research that sheds light into how metabolic disorders and abnormal dietary patterns affect psoriatic arthritis disease activity.
Dr Eder, from the University of...
08/14/2023
Rheumatology & Arthritis
Joseph Merola
Conference Coverage
Joseph Merola, MD, MMSc, on the Long-Term Efficacy of Risankizumab for PsA
07/19/2023
Dr Merola and colleagues conducted a post hoc analysis of the KEEPsAkE 1 and 2 trials of risankizumab among patients with active psoriatic arthritis to evaluates patient subgroups at 52 weeks of treatment.
Dr Merola and colleagues conducted a post hoc analysis of the KEEPsAkE 1 and 2 trials of risankizumab among patients with active psoriatic arthritis to evaluates patient subgroups at 52 weeks of treatment.
Dr Merola and colleagues...
07/19/2023
Rheumatology & Arthritis
Joseph Merola, MD
Conference Coverage
Joseph Merola, MD, on Challenges in Psoriatic Disease
07/11/2023
Dr Merola explains how other conditions can mimic psoriatic diseases and present diagnostic and treatment challenges with the help of a dermatology-rheumatology combined clinic.
Dr Merola explains how other conditions can mimic psoriatic diseases and present diagnostic and treatment challenges with the help of a dermatology-rheumatology combined clinic.
Dr Merola explains how other...
07/11/2023
Rheumatology & Arthritis
woman spine+woman back pain
Conference Coverage
Jennifer Mandal, MD, on the Rheumatology Access Expansion Initiative
06/09/2023
Dr Mandal, from the University of California, presented research she conducted with colleagues on ways to alleviate the disproportionate levels of rheumatology care among communities of color and rural populations.
Dr Mandal, from the University of California, presented research she conducted with colleagues on ways to alleviate the disproportionate levels of rheumatology care among communities of color and rural populations.
Dr Mandal, from the University...
06/09/2023
Rheumatology & Arthritis
woman writing on computer
Conference Coverage
Megan Meier, MD, on Direct-to-Patient Screening of PsA
04/11/2023
Priyam Vora
Data from the Psoriasis Epidemiology Screening Tool survey found that evaluation by a rheumatologist was beneficial in patient-driven psoriatic arthritis screening.
Data from the Psoriasis Epidemiology Screening Tool survey found that evaluation by a rheumatologist was beneficial in patient-driven psoriatic arthritis screening.
Data from the Psoriasis...
04/11/2023
Rheumatology & Arthritis
Alexis Ogdie
Conference Coverage
Alexis Ogdie, MD, on Clinical Measures and PROs in PsA
03/17/2023
Dr Ogdie, from the University of Pennsylvania, discusses the analysis of results from the KEEPsAKE trials of risankizumab regarding the association of clinical measures and patient-reported outcomes in psoriatic arthritis.
Dr Ogdie, from the University of Pennsylvania, discusses the analysis of results from the KEEPsAKE trials of risankizumab regarding the association of clinical measures and patient-reported outcomes in psoriatic arthritis.
Dr Ogdie, from the University of...
03/17/2023
Rheumatology & Arthritis
Saakshi Khattri, MD
Conference Coverage
Saakshi Khattri, MD, MBBS, on the Impact of Risankizumab on Enthesitis and Dactylitis in PsA
03/07/2023
Rebecca Mashaw
Results from the KEEPsAKE 1 and 2 trials demonstrated the efficacy of risankizumab in achieving and maintaining resolution of dactylitis and enthesitis among patients with psoriatic arthritis.
Results from the KEEPsAKE 1 and 2 trials demonstrated the efficacy of risankizumab in achieving and maintaining resolution of dactylitis and enthesitis among patients with psoriatic arthritis.
Results from the KEEPsAKE 1 and...
03/07/2023
Rheumatology & Arthritis
Laura Coates
Conference Coverage
Laura Coates, MBBS, on Upadacitinib Vs Adalimumab on RAPID3 Among Patients With Psoriatic Arthritis
02/22/2023
Dr Coates presented a poster at ACR Convergence examining the efficacy of upadacitinib vs adalimumab in treating psoriatic arthritis, using the RAPID3 tool to assess disease activity.
Dr Coates presented a poster at ACR Convergence examining the efficacy of upadacitinib vs adalimumab in treating psoriatic arthritis, using the RAPID3 tool to assess disease activity.
Dr Coates presented a poster at...
02/22/2023
Rheumatology & Arthritis
Alexis Ogdie, MD
Conference Coverage
Alexis Ogdie, MD, on PEST Screening Among Patients With PsO
02/13/2023
Rebecca Mashaw
Dr Ogdie, from the University of Pennsylvania, presented an abstract at ACR Convergence 2022 on research she and colleagues conducted highlighting the need to actively screen patients with psoriasis for their risk of developing psoriatic...
Dr Ogdie, from the University of Pennsylvania, presented an abstract at ACR Convergence 2022 on research she and colleagues conducted highlighting the need to actively screen patients with psoriasis for their risk of developing psoriatic...
Dr Ogdie, from the University of...
02/13/2023
Rheumatology & Arthritis
Lihi Eder, MD
Conference Coverage
Lihi Eder, MD, PhD, on Assessing the Effectiveness of COVID-19 Vaccines Among Patients With Psoriatic Disease
12/19/2022
Dr Eder and colleagues used data from Israeli health services to compare immune responses among patients with psoriatic arthritis and/or psoriasis and general population controls to COVID-19 vaccines.
Dr Eder and colleagues used data from Israeli health services to compare immune responses among patients with psoriatic arthritis and/or psoriasis and general population controls to COVID-19 vaccines.
Dr Eder and colleagues used data...
12/19/2022
Rheumatology & Arthritis
woman sad+depression
News
Burden of PsA Different for Men and Women, Micheala Koehm, MD, Explains
11/17/2022
Did you know psoriatic arthritis affects females in a much different way than males? Dr Michaela Koehm explained the differences in disease management and resolution between the sexes during her poster presentation at the ACR Convergence.
Did you know psoriatic arthritis affects females in a much different way than males? Dr Michaela Koehm explained the differences in disease management and resolution between the sexes during her poster presentation at the ACR Convergence.
Did you know psoriatic arthritis...
11/17/2022
Rheumatology & Arthritis
injection photo
Conference Coverage
ACR Announces Vaccination Guideline for Patients With RMDs
11/14/2022
The American College of Rheumatology announced at ACR Convergence that its guideline for vaccinations among patients with rheumatic and musculoskeletal diseases will be published in early 2023.
The American College of Rheumatology announced at ACR Convergence that its guideline for vaccinations among patients with rheumatic and musculoskeletal diseases will be published in early 2023.
The American College of...
11/14/2022
Rheumatology & Arthritis
Alexis Ogdie
Conference Coverage
Alexis Ogdie, MD, on Response Rates in PsA: Results from the KEEPsAKE Trials of Risankizumab
11/14/2022
Dr Ogdie, from the University of Pennsylvania, reviews her poster presentation from ACR Convergence 2022 on response rates among patients treated with risankizumab based on the number of swollen and tender joints, from the KEEPsAKE 1 and 2...
Dr Ogdie, from the University of Pennsylvania, reviews her poster presentation from ACR Convergence 2022 on response rates among patients treated with risankizumab based on the number of swollen and tender joints, from the KEEPsAKE 1 and 2...
Dr Ogdie, from the University of...
11/14/2022
Rheumatology & Arthritis
Kelly Gavigan, MPH
Conference Coverage
Kelly Gavigan, MPH, on Online Wellness Programs for Patients with PsA
11/12/2022
Through a cross-sectional online survey, Dr Gavighan and colleagues sought to examine the views and attitudes of individuals with psoriatic arthritis about using a guided online wellness program to manage their disease.
Through a cross-sectional online survey, Dr Gavighan and colleagues sought to examine the views and attitudes of individuals with psoriatic arthritis about using a guided online wellness program to manage their disease.
Through a cross-sectional online...
11/12/2022
Rheumatology & Arthritis
woman in hospital
Conference Coverage
Fatigue Drives Health Care Costs in PsA
07/22/2022
A study presented at ACR Convergence 2021 shows that patients with psoriatic arthritis who also suffer from fatigue incurred higher resource use and health care costs than those without fatigue.
A study presented at ACR Convergence 2021 shows that patients with psoriatic arthritis who also suffer from fatigue incurred higher resource use and health care costs than those without fatigue.
A study presented at ACR...
07/22/2022
Rheumatology & Arthritis
spinal xray
Conference Coverage
PsA Carries Risk of Vertebral Fracture
02/18/2022
A new study demonstrates that patients with psoriatic arthritis, as in other inflammatory diseases, are at higher risk of fractures in the vertebrae.
A new study demonstrates that patients with psoriatic arthritis, as in other inflammatory diseases, are at higher risk of fractures in the vertebrae.
A new study demonstrates that...
02/18/2022
Rheumatology & Arthritis
Orbai
Podcast
Ana-Maria Orbai, MD, on Validating the PROMIS 29 Profile for PsA
01/31/2022
Dr Orbai, from Johns Hopkins University, discusses her project to validate the PROMIS 29 profile for use in assessing several disease domains among patients with psoriatic arthritis, which she spoke about at ACR Convergence 2021.
Dr Orbai, from Johns Hopkins University, discusses her project to validate the PROMIS 29 profile for use in assessing several disease domains among patients with psoriatic arthritis, which she spoke about at ACR Convergence 2021.
Dr Orbai, from Johns Hopkins...
01/31/2022
Rheumatology & Arthritis
Orbai
Podcast
Ana-Maria Orbai, MD, on the DISCOVER 1 Trial of Guselkumab for Psoriatic Arthritis
12/07/2021
Dr Orbai, from Johns Hopkins University, recaps a presentation on the findings of a trial of guselkumab for the treatment of psoriatic arthritis at ACR Convergence 2021.
Dr Orbai, from Johns Hopkins University, recaps a presentation on the findings of a trial of guselkumab for the treatment of psoriatic arthritis at ACR Convergence 2021.
Dr Orbai, from Johns Hopkins...
12/07/2021
Rheumatology & Arthritis
Al Kim
Video
Alfred Kim, MD, on the Immunogenicity of Vaccine Responses Among Patients With Rheumatic Diseases
12/06/2021
Dr Kim, from Washington University School of Medicine, discusses recent research he presented at the ACR Convergence demonstrating how patients on various immunosuppressive therapies respond to vaccines—including the vaccine against...
Dr Kim, from Washington University School of Medicine, discusses recent research he presented at the ACR Convergence demonstrating how patients on various immunosuppressive therapies respond to vaccines—including the vaccine against...
Dr Kim, from Washington...
12/06/2021
Rheumatology & Arthritis
For patients with Behçet disease, ophthalmological involvement is one of the most feared manifestations.
Conference Coverage
Ocular Involvement Among Patients With Behçet’s Disease
11/23/2021
A study presented at the ACR 2021 Convergence found that among patients with Behçet’s disease, the most frequent ocular manifestations were uveitis and retinal vasculitis.
A study presented at the ACR 2021 Convergence found that among patients with Behçet’s disease, the most frequent ocular manifestations were uveitis and retinal vasculitis.
A study presented at the ACR...
11/23/2021
Autoimmune
an elderly person's hand
Conference Coverage
Peer Coaching for Systemic Sclerosis Management
11/23/2021
A web-based program for systemic sclerosis symptom management proved feasible and received positive feedback from participants.
A web-based program for systemic sclerosis symptom management proved feasible and received positive feedback from participants.
A web-based program for systemic...
11/23/2021
Rheumatology & Arthritis
phone & laptop
Conference Coverage
The Impact of Interdisciplinary Care on Remission of PsA and PsO
11/18/2021
Researchers presented an abstract at ACR Convergence 2021 examining how collaborative care by rheumatologists and dermatologists can benefit patients with psoriasis and psoriatic arthritis.
Researchers presented an abstract at ACR Convergence 2021 examining how collaborative care by rheumatologists and dermatologists can benefit patients with psoriasis and psoriatic arthritis.
Researchers presented an...
11/18/2021
Rheumatology & Arthritis
CT
Conference Coverage
Researchers Find Imaging Technique Can Distinguish PsA from Other Arthritides
11/12/2021
An abstract presented at the American College of Rheumatology 2021 Convergence validated Total-Body 18F-FDG PET/CT imaging for accurately diagnosing psoriatic arthritis.
An abstract presented at the American College of Rheumatology 2021 Convergence validated Total-Body 18F-FDG PET/CT imaging for accurately diagnosing psoriatic arthritis.
An abstract presented at the...
11/12/2021
Rheumatology & Arthritis
Eyeball
Conference Coverage
Prevalence of Uveitis Among Patients With PsA vs General Population
11/08/2021
Study findings show the hazard ratio for uveitis was significantly higher among patients with psoriatic arthritis compared to the general population.
Study findings show the hazard ratio for uveitis was significantly higher among patients with psoriatic arthritis compared to the general population.
Study findings show the hazard...
11/08/2021
Rheumatology & Arthritis
blood vials
Conference Coverage
Guselkumab Lessens Prevalence of Anemia Among Patients With PsA
11/08/2021
Findings from 2 randomized clinical trials suggest treatment with guselkumab increases hemoglobin levels and lessens the prevalence of anemia among patients with PsA.
Findings from 2 randomized clinical trials suggest treatment with guselkumab increases hemoglobin levels and lessens the prevalence of anemia among patients with PsA.
Findings from 2 randomized...
11/08/2021
Rheumatology & Arthritis
person holding knee
Conference Coverage
Pain Relief in PsA Associated With Other Improvements in PROs
11/07/2021
A phase 3 trial tests upacitinib and adalimumab for pain relief among patients with psoriatic arthritis and shows association with other improvements in patient-reported outcomes.
A phase 3 trial tests upacitinib and adalimumab for pain relief among patients with psoriatic arthritis and shows association with other improvements in patient-reported outcomes.
A phase 3 trial tests upacitinib...
11/07/2021
Rheumatology & Arthritis
laptop and stethoscope
Conference Coverage
Can EULAR/ACR Criteria Scores Predict SLE Outcomes?
11/07/2021
Investigators sought to determine whether the EULAR/ACR Classification Criteria for systemic lupus erythematosus was predictive of damage and mortality.
Investigators sought to determine whether the EULAR/ACR Classification Criteria for systemic lupus erythematosus was predictive of damage and mortality.
Investigators sought to...
11/07/2021
Rheumatology & Arthritis
pulse ox
Conference Coverage
Improvements in Scleroderma Monitoring Enable Early Detection of Lung Disease
11/06/2021
Clinicians in a rural medical center sought to improve early detection of interstitial lung disease and pulmonary hypertension among patients with scleroderma.
Clinicians in a rural medical center sought to improve early detection of interstitial lung disease and pulmonary hypertension among patients with scleroderma.
Clinicians in a rural medical...
11/06/2021
Rheumatology & Arthritis
injection photo
Conference Coverage
COVID-19 Vaccine Efficacy Appears Attenuated Among Patients With Rheumatic Diseases
11/06/2021
An abstract presented at ACR Convergence indicated that patients with rheumatic diseases mounted a lower immune response to mRNA vaccines against COVID-19 than the general population.
An abstract presented at ACR Convergence indicated that patients with rheumatic diseases mounted a lower immune response to mRNA vaccines against COVID-19 than the general population.
An abstract presented at ACR...
11/06/2021
Rheumatology & Arthritis
hands
Conference Coverage
RD Care Teams Should Address Mental Health Changes From Pandemic
11/06/2021
Study findings suggest that the psychosocial toll of the pandemic on patients with rheumatic disease supports the need for care teams to assess and address mental health side effects.
Study findings suggest that the psychosocial toll of the pandemic on patients with rheumatic disease supports the need for care teams to assess and address mental health side effects.
Study findings suggest that the...
11/06/2021
Rheumatology & Arthritis
xray
Conference Coverage
Impact of Symptomatic Multijoint Osteoarthritis Subtypes on Physical Function
11/06/2021
Specific subtypes of symptomatic multi-joint osteoarthritis, in which at least one joint site is symptomatic, are associated with varying decrements in self-reported physical function.
Specific subtypes of symptomatic multi-joint osteoarthritis, in which at least one joint site is symptomatic, are associated with varying decrements in self-reported physical function.
Specific subtypes of symptomatic...
11/06/2021
Rheumatology & Arthritis
chest xray
Conference Coverage
Airway Disease Seen in Most Newly Diagnosed Patients With RA
11/06/2021
Researchers found that while a majority of patients with rheumatoid arthritis diagnosed within the previous 2 years had airway disease, in most the disease was mild and required no change in treatment.
Researchers found that while a majority of patients with rheumatoid arthritis diagnosed within the previous 2 years had airway disease, in most the disease was mild and required no change in treatment.
Researchers found that while a...
11/06/2021
Rheumatology & Arthritis
kidney
Conference Coverage
Voclosporin Shows Efficacy in Lupus Nephritis
11/23/2011
In the interim analysis of the AURORA 2 Extension Study, the addition of voclosporin to a mycophenolate mofetil and low-dose steroid treatment routine has proved effective at reducing proteinuria.
In the interim analysis of the AURORA 2 Extension Study, the addition of voclosporin to a mycophenolate mofetil and low-dose steroid treatment routine has proved effective at reducing proteinuria.
In the interim analysis of the...
11/23/2011
Autoimmune
woman and doctor
Conference Coverage
Rates of Short-Term Disability Associated With Fatigue Among Patients With PsA
11/16/2011
Higher rates of annual short-term disability were observed among patients with PsA and fatigue than without fatigue, according to a study presented at ACR Convergence 2021.
Higher rates of annual short-term disability were observed among patients with PsA and fatigue than without fatigue, according to a study presented at ACR Convergence 2021.
Higher rates of annual...
11/16/2011
Gastroenterology
man with tape measure
Conference Coverage
Association Between BMI and Treatment Response Among Patients With PsA
11/04/2011
Study findings suggest changes in patient-reported outcomes measures were lowest among patients with PsA and obesity compared to other BMI categories.
Study findings suggest changes in patient-reported outcomes measures were lowest among patients with PsA and obesity compared to other BMI categories.
Study findings suggest changes...
11/04/2011
Rheumatology & Arthritis
pills
Conference Coverage
AS Treatment Shows Variability Based on Provider
11/07/2010
A study presented at ACR Convergence 2021 revealed that primary care providers prescribed more pain relievers and fewer disease-modifying antirheumatic drugs than rheumatologists for patients with AS.
A study presented at ACR Convergence 2021 revealed that primary care providers prescribed more pain relievers and fewer disease-modifying antirheumatic drugs than rheumatologists for patients with AS.
A study presented at ACR...
11/07/2010
Rheumatology & Arthritis
Conference Coverage
Clinical-Genetic Risk Score Developed for ILD Among Patients With RA
11/10/2002
A new risk score for development of interstitial lung disease among patients with rheumatoid arthritis beats clinical factors alone, according to an abstract presented by Dr Austin Wheeler at ACR Convergence.
A new risk score for development of interstitial lung disease among patients with rheumatoid arthritis beats clinical factors alone, according to an abstract presented by Dr Austin Wheeler at ACR Convergence.
A new risk score for development...
11/10/2002
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use